BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Li S, Yao Y, Yin W, Ye T. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. Food Funct 2021;12:990-1007. [PMID: 33459740 DOI: 10.1039/d0fo03001e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Zhang Y, Xu D, Wang Y, Pan D, Wang P, Xia J, Yin S, Liao W, Wang S, Sun G. Tocotrienol-Rich Fractions Offer Potential to Suppress Pulmonary Fibrosis Progression. IJMS 2022;23:14331. [DOI: 10.3390/ijms232214331] [Reference Citation Analysis]
2 Zhao W, Cheng J, Luo Y, Fu W, Zhou L, Wang X, Wang Y, Yang Z, Yao X, Ren M, Zhong Z, Wu X, Ren Z, Li Y. MicroRNA let-7f-5p regulates PI3K/AKT/COX2 signaling pathway in bacteria-induced pulmonary fibrosis via targeting of PIK3CA in forest musk deer. PeerJ 2022;10:e14097. [DOI: 10.7717/peerj.14097] [Reference Citation Analysis]
3 Wang Y, Wei J, Deng H, Zheng L, Yang H, Lv X. The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches. Antioxidants 2022;11:1685. [DOI: 10.3390/antiox11091685] [Reference Citation Analysis]
4 Li J, Wang Y, Wang R, Wu MY, Shan J, Zhang YC, Xu HM. Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification. Heliyon 2022;8:e10201. [PMID: 36046534 DOI: 10.1016/j.heliyon.2022.e10201] [Reference Citation Analysis]
5 Zhang XL, Li B, Zhang X, Zhu J, Xie Y, Shen T, Tang W, Zhang J. 18β-Glycyrrhetinic acid monoglucuronide (GAMG) alleviates single-walled carbon nanotubes (SWCNT)-induced lung inflammation and fibrosis in mice through PI3K/AKT/NF-κB signaling pathway. Ecotoxicol Environ Saf 2022;242:113858. [PMID: 35809393 DOI: 10.1016/j.ecoenv.2022.113858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liang Y, Sun L, Rong F, Han X, Ma X, Deng X, Cheng M, Shan J, Li W, Fu T. Inhalation of tetrandrine liposomes for the treatment of bleomycin induced idiopathic pulmonary fibrosis. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103492] [Reference Citation Analysis]
7 Lu Y, Zhang Y, Pan Z, Yang C, Chen L, Wang Y, Xu D, Xia H, Wang S, Chen S, Hao YJ, Sun G. Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways. Nutrients 2022;14:1094. [DOI: 10.3390/nu14051094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Hasan M, Paul NC, Paul SK, Saikat ASM, Akter H, Mandal M, Lee SS. Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules 2022;27:1481. [PMID: 35268581 DOI: 10.3390/molecules27051481] [Reference Citation Analysis]
9 Estornut C, Milara J, Bayarri MA, Belhadj N, Cortijo J. Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis. Front Pharmacol 2022;12:794997. [DOI: 10.3389/fphar.2021.794997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Rezaee R, Hosseinzadeh H. Pulmonary Fibrosis. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00131-6] [Reference Citation Analysis]
11 Guo C, Zhang C, Xia Z, Song B, Hu W, Cui Y, Xue Y, Xia M, Xu D, Zhang S, Fang J. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation. J Control Release 2021;341:566-77. [PMID: 34864115 DOI: 10.1016/j.jconrel.2021.11.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu J, Liu L, Zhang G, Peng X. Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis. Int J Biol Macromol 2021;189:346-55. [PMID: 34428489 DOI: 10.1016/j.ijbiomac.2021.08.139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
13 Timalsina D, Pokhrel KP, Bhusal D. Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations. Biomed Res Int 2021;2021:1636816. [PMID: 34646882 DOI: 10.1155/2021/1636816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Huang YY, Deng J, Tian YJ, Liang J, Xie X, Huang Y, Zhu J, Zhu Z, Zhou Q, He X, Luo HB. Mangostanin Derivatives as Novel and Orally Active Phosphodiesterase 4 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis with Improved Safety. J Med Chem 2021;64:13736-51. [PMID: 34520193 DOI: 10.1021/acs.jmedchem.1c01085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Tan S, Chen S. The Mechanism and Effect of Autophagy, Apoptosis, and Pyroptosis on the Progression of Silicosis. Int J Mol Sci 2021;22:8110. [PMID: 34360876 DOI: 10.3390/ijms22158110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]